Tempest Therapeutics raises ~$2.5M via private placement of pre-funded and common warrants

Tempest Therapeutics, Inc.

Issued pre-funded warrants for 3,105,591 shares at $0.001 exercise price, plus Series C/D warrants for same count.
Combined price $0.804 per unit; gross proceeds ~$2.5M, up to ~$5M more if common warrants exercised.
Series C warrants ($0.805 strike, 6yr) and Series D (3yr) exercisable after stockholder approval; 90 days to seek approval.
H.C. Wainwright placement agent; 7% cash fee and warrants for 217,391 shares at $1.0063.
Proceeds for working capital; 30-day lock-up on new issuance, 60-day ban on variable-rate deals.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.